What is the interpretation of a negative typhoid IgG and IgM, a positive Tubex test, and a Widal O‑antigen titer of 1:160?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation of Typhoid Serological Test Results

This serological pattern suggests probable acute or recent typhoid fever infection that warrants empirical antibiotic treatment while awaiting blood culture confirmation. The positive TUBEX test combined with elevated Widal O antigen titer (1:160) indicates likely active infection, despite negative IgG and IgM results.

Understanding the Discordant Results

The combination of negative typhoid-specific IgG/IgM with positive TUBEX and elevated Widal O titer is not uncommon and reflects the different methodologies and timing sensitivities of these tests:

TUBEX Test (Positive)

  • Most significant finding: TUBEX detects anti-O9 antibodies (both IgM and IgG combined) through an inhibition assay 1
  • Research shows TUBEX has 91.2% sensitivity in the first week of fever in endemic areas 2
  • The test detects antibodies not necessarily IgM alone, but IgM working together with IgG antibodies 2
  • This positive result carries substantial diagnostic weight for acute infection

Widal O Antigen 1:160

  • Moderately supportive: A titer of 1:160 has demonstrated 61.2% sensitivity and high specificity in culture-confirmed typhoid fever 3
  • Guidelines explicitly state the Widal test lacks sensitivity and specificity and is not recommended as a standalone diagnostic 4
  • However, when combined with other positive findings, this titer supports the diagnosis

Negative IgG and IgM

  • These likely represent standard ELISA or rapid diagnostic tests
  • May be negative due to:
    • Early infection timing (antibodies not yet detectable by this specific assay)
    • Different antigen targets than TUBEX
    • Lower analytical sensitivity compared to TUBEX methodology
    • Test quality variations (some rapid tests show false-negative rates)

Clinical Action Required

Blood culture remains the gold standard and should be obtained immediately if not already done 4:

  • Sensitivity: 40-80% (highest yield within first week of symptoms)
  • Two sets should be collected before starting antibiotics 4

Treatment Recommendation

Start empirical antibiotic therapy immediately if clinical suspicion is high and the patient appears unstable 4:

  • First-line: Intravenous ceftriaxone (preferred due to widespread fluoroquinolone resistance >70% of imported isolates) 4
  • Oral alternative: Azithromycin for uncomplicated disease if fluoroquinolone resistance confirmed 4
  • Duration: 14 days to reduce relapse risk 4

Important Caveats

Do not delay treatment waiting for culture results if:

  • Patient has fever with compatible clinical presentation (headache, abdominal pain, constipation/diarrhea)
  • Travel history to endemic areas (South/Southeast Asia, Africa, South America)
  • Patient appears clinically unstable

Beware of false positives: Recent COVID-19 vaccination (particularly Pfizer-BioNTech) can cause false-positive Widal results 5, though this would not explain the positive TUBEX test.

Bottom Line

The positive TUBEX test is your most reliable indicator here, supported by the Widal O titer of 1:160. The negative IgG/IgM should not dissuade you from the diagnosis. Treat as presumptive typhoid fever with appropriate antibiotics while awaiting blood culture confirmation, especially if clinical presentation and epidemiological factors support enteric fever 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.